Literature DB >> 14642448

Differential effects of NK1 receptors in the midbrain periaqueductal gray upon defensive rage and predatory attack in the cat.

Thomas R Gregg1, Allan Siegel.   

Abstract

This study utilized anatomical and behavioral-pharmacological methods to determine the role of NK(1)-Substance P receptors in the midbrain periaqueductal gray (PAG) in defensive rage behavior in cats. For behavioral pharmacological experiments, monopolar stimulating electrodes were implanted in the medial hypothalamus for elicitation of defensive rage behavior and cannula-electrodes were implanted in the PAG for microinjections of receptor compounds. Microinjections of the NMDA antagonist, AP-7 (2 nmol), into the dorsal PAG blocked defensive rage elicited by medial hypothalamic stimulation, thus establishing the PAG as a synaptic region that receives hypothalamic inputs linked to defensive rage behavior. Microinjections of the NK(1) agonist, GR73632, into the same injection sites facilitated defensive rage in a dose-dependent manner, and also induced spontaneous hissing in five cats. The effects of GR73632 were reduced by pretreatment of the PAG with the NK(1) antagonist, GR82334 (16 nmol), microinjected into the same sites. Microinjections of GR73632 (8 nmol) into the PAG also suppressed predatory attack elicited by stimulation of the lateral hypothalamus. Immunohistochemical methods utilized to detect Substance P and Fos immunoreactivity revealed that neurons in the PAG activated after defensive rage-inducing medial hypothalamic stimulation lie in the same region as Substance-P-immunoreactive processes. Fos immunoreactivity was highest in the dorsomedial aspect of the rostral PAG after medial hypothalamic stimulation. Cats that were unstimulated or that exhibited predatory attack after lateral hypothalamic stimulation had low c-fos expression levels in the PAG. Substance P immunoreactivity was high throughout the dorsal PAG. The results indicate that NK(1) receptors in the PAG potentiate defensive rage and suppress predatory aggression in the cat.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14642448     DOI: 10.1016/j.brainres.2003.09.024

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Effects of substance P in the amygdala, ventromedial hypothalamus, and periaqueductal gray on fear-potentiated startle.

Authors:  Zuowei Zhao; Yong Yang; David L Walker; Michael Davis
Journal:  Neuropsychopharmacology       Date:  2008-04-16       Impact factor: 7.853

2.  Hierarchical Representations of Aggression in a Hypothalamic-Midbrain Circuit.

Authors:  Annegret L Falkner; Dongyu Wei; Anjeli Song; Li W Watsek; Irene Chen; Patricia Chen; James E Feng; Dayu Lin
Journal:  Neuron       Date:  2020-03-11       Impact factor: 17.173

3.  An NK1 receptor antagonist microinjected into the periaqueductal gray blocks lateral hypothalamic-induced antinociception in rats.

Authors:  Janean E Holden; Julie A Pizzi; Younhee Jeong
Journal:  Neurosci Lett       Date:  2009-02-07       Impact factor: 3.046

4.  Role of IL-1 beta and 5-HT2 receptors in midbrain periaqueductal gray (PAG) in potentiating defensive rage behavior in cat.

Authors:  Suresh Bhatt; Rekha Bhatt; Steven S Zalcman; Allan Siegel
Journal:  Brain Behav Immun       Date:  2007-09-24       Impact factor: 7.217

5.  The neurobiological bases for development of pharmacological treatments of aggressive disorders.

Authors:  Allan Siegel; Suresh Bhatt; Rekha Bhatt; Steven S Zalcman
Journal:  Curr Neuropharmacol       Date:  2007       Impact factor: 7.363

6.  Peripheral and central mediators of lipopolysaccharide induced suppression of defensive rage behavior in the cat.

Authors:  S Bhatt; R S Bhatt; S S Zalcman; A Siegel
Journal:  Neuroscience       Date:  2009-07-30       Impact factor: 3.590

7.  Role of human HGFIN/nmb in breast cancer.

Authors:  Rebecca L Metz; Prem S Patel; Meera Hameed; Margaret Bryan; Pranela Rameshwar
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.